SCHEMBL20127318

SCHEMBL20127318

c1cc(-c2ccc3oc4ccccc4c3c2)cc(-c2c3ccccc3c(-c3ccc4oc5ccc6ccccc6c5c4c3)c3ccccc23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.43
PLA2G4A P47712 3/20 0.43
PLA2G10 O15496 1/20 0.43
ABCG2 Q9UNQ0 5/20 0.43
AHR P35869 3/20 0.43
PAX8 Q06710 2/20 0.43
CYP1A1 P04798 1/20 0.43
CYP1A2 P05177 1/20 0.43
FYN P06241 1/20 0.43
MAPK3 P27361 1/20 0.43
NPC1 O15118 3/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TDP1 Q9NUW8 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122710 0.96 ABCG2 (0.46) PLA2G2APLA2G4APLA2G10ABCG2AHR
SCHEMBL20127306 0.94 KDM4E (0.45) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL20127591 0.93 TDP1 (0.43) PLA2G2APLA2G4APLA2G10ABCG2AHR
SCHEMBL10122539 0.93 ABCG2 (0.47) PLA2G2APLA2G4APLA2G10ABCG2AHR
SCHEMBL10122499 0.93 ABCG2 (0.47) PLA2G2APLA2G4APLA2G10ABCG2AHR
SCHEMBL10122535 0.93 ABCG2 (0.47) PLA2G2APLA2G4APLA2G10ABCG2AHR
SCHEMBL20127312 0.93 NPC1 (0.41) PLA2G2APLA2G4AABCG2AHRPAX8
SCHEMBL22218984 0.93 KDM4E (0.44) ABCG2AHRPAX8CYP1A1CYP1A2
SCHEMBL12338264 0.92 TDP1 (0.41) PLA2G2APLA2G4APLA2G10ABCG2AHR
SCHEMBL12338280 0.92 TDP1 (0.41) PLA2G2APLA2G4APLA2G10ABCG2AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180208836-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-07-26 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180130968-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE RER1, NR0B1, NR2E1 PLA2G2A 2960/4885PLA2G4A 3780/4885PLA2G10 4476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.